A glimpse into the future: recombinant proteins and small molecules for targeted therapies in rheumatic diseases

Whether the differences in the clinical picture and in the pathogenesis between rheumatoid arthritis (RA) and ankylosing spondylitis (AS) will lead to different therapeutic approaches is unclear at present. Since anti-TNF-alpha agents and other biologics are not efficacious in all patients new devel...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental rheumatology 2009-07, Vol.27 (4 Suppl 55), p.S168-S170
Hauptverfasser:	Kalden, J R, Braun, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antirheumatic Agents Arthritis, Rheumatoid - therapy Biological Therapy - methods Biological Therapy - trends Disease Models, Animal Humans Recombinant Proteins Rheumatology - trends Spondylitis, Ankylosing - therapy Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Whether the differences in the clinical picture and in the pathogenesis between rheumatoid arthritis (RA) and ankylosing spondylitis (AS) will lead to different therapeutic approaches is unclear at present. Since anti-TNF-alpha agents and other biologics are not efficacious in all patients new developments are clearly needed.
ISSN:	0392-856X